Transition Behavior in the Use of Complementary and Alternative Medicine during Follow-up after Radical Prostatectomy: A Multicenter Survey in Japan

Koji Yoshimura, Yoshiteru Sumiyoshi, Toshiyuki Kamoto, Osamu Ogawa, Yoichi Arai, Yoshiyuki Kakehi, Akito Terai, Hiroshi Kanamaru, Mutsushi Kawakita, Naoko Kinukawa

.

DOI: 10.4236/health.2010.212217                

Abstract

We evaluated the prevalence of use of complementary and alternative medicine (CAM), as well as the transitional nature of its use, before and after radical prostatectomy in Japa-nese patients with localized prostate cancer. Methods: We enrolled 376 patients, who an-swered a self-administered questionnaire on CAM use, psychological health locus of control (HLC), and general-health-related quality of life (GHQL). Detailed information regarding CAM use according to the transtheoretical model, and the time at initiation and abandonment of CAM use were assessed. Medical information was also extracted from patient charts. Results: 45.7% of patients belonged to the “precontem-plation” stage, 29.8% to the “contemplation” stage, 1.9% to the “preparation” stage, 14.4% to the “action” stage, and 8.2% to the “relapse” stage. Although patient age and educational status had a significant impact on stage of CAM use, HLC and GHQL were not associated with them. The time-course of prevalence of CAM use during follow-up was divided into three phases: “initial,” “rapid-increase,” and “main-tenance”. Conclusions: Among patients under-going radical prostatectomy, non-users can be classified into several behavioral stages, while users do not use CAM constantly during fol-low-up.

Keywords

Prostate Cancer; Alternative Medicine; Health Survey; Health Locus Of Control; Epidemiology

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. (1993) Unconventional medicine in the United States: prevalence, costs, and patterns of use. New Engl J Med , 328: 246-52.
[2]	Lippert MC, McClain R, Boyd JC, Theodorescu D. (1999) Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer , 86: 2642-8
[3]	Kao GD, Devine P. (2000) Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer , 88: 615-9
[4]	Nam RK, Fleshner N, Rakovitch E, et al. (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis. J Urol ,161: 1521-4
[5]	Wilkinson S, Gomella LG, Smith JA, et al. (2002) Attitudes and use of complementary medicine in men with prostate cancer. J Urol , 168: 2505-9
[6]	Boon H, Westlake K, Stewart M, et al. (2003) Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology , 62: 849-53
[7]	Diefenbach MA, Hamrick N, Uzzo R, et al. (2003) Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. J Urol , 170: 166-9
[8]	Ponholzer A, Struhal G, Madersbacher S. (2003) Frequent use of complementary medicine by prostate cancer patients. Eur Urol , 43: 604-8
[9]	Hall JD, Bissonette EA, Boyd JC, Theodorescu D. (2003) Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. BJU Int , 91: 603-7
[10]	Beebe-Dimmer JL, Wood Jr. DP, Gruber SB, et al. (2004) Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology , 63: 282-7
[11]	Eng J, Ramsum D, Verfoef M, Guns E, Davison J, Gallagher R. (2003) A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther , 2: 212-6
[12]	Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. (2005) Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology , 66: 1223-8
[13]	Jones RA, Taylor AG, Bourguignon C, et al. (2007) Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncol Nurs Forum ,34: 359-64
[14]	Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y. (2003) Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan. Int J Clin Oncol , 8: 26-30
[15]	Yoshimura K, Ueda N, Ichioka K, Matsui Y, Terai A, Arai Y. (2005) Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution. Support Care Cancer , 13: 685-90
[16]	Prochaska JO, DiClemente CC. (1983) Stages and processes of self-change of smoking: toward an integral model of change. J Consult Clin Psychol , 51: 390-5
[17]	Horige Y. (1991) Development of Japanese version of health locus of control. Kenkoshinrigakukenkyu , 4: 1-7 (in Japanese)
[18]	Fukuhara S, Suzukamo Y. (2004) Manual of the SF-8 Japanese version. Institute for Health Outcomes & Process Evaluation Research Kyoto
[19]	Sumiyoshi Y, Hashine K, Koizumi T, Azuma K, Hyodo K. (2003) Use of complementary and alternative medicine in prostate cancer patients. Nippon Hinyokika Gakkaishi ,94: 328 (in Japanese)
[20]	Hirai K, Komura K, Tokoro A, et al. (2008) Psychological and behavioral mechanisms influencing the use of complementary and alternative medicine (CAM) in cancer patients. Ann Oncol , 19: 45-55
[21]	Cassileth BR, Lusk EJ, Guerry D, et al. (1991) Survival and quality of life among patients receiving unproven as compared with conventional cancer therapy. New Engl J Med , 324: 1180-5
[22]	Boon H, Westlake K, Deber R, Moineddin R. (2005) Problem-solving and decision-making preferences: no difference between complementary and alternative medicine users and non-users. Complement Ther Med , 13: 213-6
[23]	Steginga SK, Occhipinti S, Gardiner RAF, Yaxley J, Heathcote P. (2004) A prospective study of the use of alternative therapies by men with localized prostate cancer. Patient Educ Couns , 55: 70-7